The content discusses Abiomed's recall of the instructions for use (IFU) for its Impella left-sided blood pumps due to potential risks associated with the pump catheter perforating the left ventricle wall. The recall, classified as Class I by the FDA, highlights the serious health consequences that may arise from the use of affected pumps, including injuries and deaths. The recall covers various Impella models distributed within a specific timeframe and provides guidelines for healthcare professionals to mitigate risks. Abiomed had previously recalled these pumps in the US due to safety concerns related to transcatheter aortic valve replacement (TAVR) stents.
다른 언어로
소스 콘텐츠 기반
www.medscape.com
핵심 통찰 요약
by Megan Brooks 게시일 www.medscape.com 03-21-2024
https://www.medscape.com/viewarticle/another-class-i-recall-abiomed-impella-left-sided-blood-2024a10005bj더 깊은 질문